{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:45:59Z","timestamp":1791755159424,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacl.2026.08.024","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:46:31Z","timestamp":1788417991000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current challenges in diagnosing homozygous familial hypercholesterolemia: Insights from the historical evolution of diagnostic criteria"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5185-3666","authenticated-orcid":false,"given":"Daniel","family":"Gaudet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2542-9930","authenticated-orcid":false,"given":"Richard","family":"Godin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Rosenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.08.024_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2018.06.855","article-title":"Epidemiology of familial hypercholesterolaemia: community and clinical","volume":"277","author":"Vallejo-Vaz","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.024_bib2","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1161\/CIR.0000000000001457","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"153","author":"Blumenthal","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.08.024_bib3","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1093\/eurjpc\/zwad203","article-title":"Modelling the potential long-term survival benefit of evinacumab treatment vs. standard of care in patients with homozygous familial hypercholesterolaemia","volume":"30","author":"Gu","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2026.08.024_bib4","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.08.024_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029175","article-title":"Contemporary homozygous familial hypercholesterolemia in the United States: insights from the CASCADE FH registry","volume":"12","author":"Cuchel","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2026.08.024_bib6","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.08.024_bib7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.atherosclerosis.2016.03.009","article-title":"Phenotype diversity among patients with homozygous familial hypercholesterolemia: a cohort study","volume":"248","author":"Raal","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.024_bib8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jacl.2026.01.011","article-title":"Update on familial hypercholesterolemia: an expert clinical consensus from the National Lipid Association","volume":"20","author":"Ahmad","year":"2026","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.024_bib9","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 update on European Atherosclerosis Society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2026.08.024_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11883-024-01269-5","article-title":"Homozygous familial hypercholesterolemia treatment: new developments","volume":"27","author":"Blom","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2026.08.024_bib11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archinte.1939.00190040016002","article-title":"Angina pectoris in hereditary xanthomatosis","volume":"64","author":"M\u00fcller","year":"1939","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2026.08.024_bib12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0002-9343(64)90196-2","article-title":"The inheritance of essential familial hypercholesterolemia","volume":"37","author":"Khachadurian","year":"1964","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2026.08.024_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM196701262760406","article-title":"Fat transport in lipoproteins--an integrated approach to mechanisms and disorders","volume":"276","author":"Fredrickson","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.08.024_bib14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2026.08.024_bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1073\/pnas.86.2.587","article-title":"Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100","volume":"86","author":"Soria","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacl.2026.08.024_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association expert panel on familial hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.024_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2026.08.024_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1297\/cpe.30.201","article-title":"A case of autosomal recessive hypercholesterolemia with a novel mutation in the LDLRAP1 gene","volume":"30","author":"Nikasa","year":"2021","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.jacl.2026.08.024_bib19","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacasi.2025.06.006","article-title":"Subclassification of phenotypic homozygous familial hypercholesterolemia","volume":"5","author":"Tada","year":"2025","journal-title":"JACC Asia"},{"key":"10.1016\/j.jacl.2026.08.024_bib20","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S2213-8587(25)00286-4","article-title":"Recent advances in research and care of familial hypercholesterolaemia","volume":"13","author":"Santos","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacl.2026.08.024_bib21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2213-8587(16)30041-9","article-title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society severe familial hypercholesterolemia panel","volume":"4","author":"Santos","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacl.2026.08.024_bib22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia","volume":"303","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.jacl.2026.08.024_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2026.08.024_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacl.2026.08.024_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.atherosclerosissup.2014.07.004","article-title":"Recommendations for the management of patients with homozygous familial hypercholesterolaemia: overview of a new European Atherosclerosis Society consensus statement","volume":"15","author":"Bruckert","year":"2014","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.jacl.2026.08.024_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jacl.2014.09.005","article-title":"The doctor's dilemma: challenges in the diagnosis and care of homozygous familial hypercholesterolemia","volume":"8","author":"Baum","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.024_bib27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41569-023-00892-0","article-title":"International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia","volume":"20","author":"Watts","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacl.2026.08.024_bib28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.5551\/jat.CR005","article-title":"Guidelines for the diagnosis and treatment of adult familial hypercholesterolemia 2022","volume":"30","author":"Harada-Shiba","year":"2023","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2026.08.024_bib29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jacasi.2023.07.011","article-title":"Clinical characteristics of homozygous familial hypercholesterolemia in Japan: a survey using a national database","volume":"3","author":"Takeji","year":"2023","journal-title":"JACC Asia"},{"key":"10.1016\/j.jacl.2026.08.024_bib30","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.08.024_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/science.ady7186","article-title":"The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR","volume":"391","author":"Tabet","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.jacl.2026.08.024_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MOL.0000000000000664","article-title":"Autosomal recessive hypercholesterolemia: update for 2020","volume":"31","author":"D'Erasmo","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.024_bib33","first-page":"1457","article-title":"Simulation model to estimate pretreatment (baseline) low-density lipoprotein cholesterol levels in people living with homozygous familial hypercholesterolemia","volume":"19","author":"Gu","year":"2025","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.024_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120590","article-title":"Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: an international collaboration","volume":"412","author":"John Mancini","year":"2026","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.024_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for homozygous familial hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jacl.2026.08.024_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.atherosclerosis.2021.07.007","article-title":"Cutaneous manifestations in familial hypercholesterolaemia","volume":"333","author":"Katzmann","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.08.024_bib37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.amjmed.2021.09.026","article-title":"Eruptive xanthomas: importance of recognition to reduce delay of effective triglyceride reduction","volume":"135","author":"Marogi","year":"2022","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2026.08.024_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5551\/jat.46979","article-title":"Application of the Japanese guidelines for the diagnosis of familial hypercholesterolemia in general practice: it is to be validated in international harmonization","volume":"26","author":"Tanaka","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2026.08.024_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jacl.2024.12.002","article-title":"Achilles tendon palpation for diagnosis of familial hypercholesterolemia: the compelling need to restore a valuable lost art","volume":"19","author":"Brinton","year":"2025","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.024_bib40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5551\/jat.CR003","article-title":"Guidelines for diagnosis and treatment of familial hypercholesterolemia 2017","volume":"25","author":"Harada-Shiba","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2026.08.024_bib41","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.08.024_bib42","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","article-title":"Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association expert panel on familial hypercholesterolemia","volume":"5","author":"Daniels","year":"2011","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.024_bib43","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/jamacardio.2025.4053","article-title":"Should familial hypercholesterolemia be included in newborn screening?","volume":"10","author":"Rader","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2026.08.024_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5334\/gh.1316","article-title":"It is time to screen for homozygous familial hypercholesterolemia in the United States","volume":"19","author":"Gidding","year":"2024","journal-title":"Glob Heart"},{"key":"10.1016\/j.jacl.2026.08.024_bib45","doi-asserted-by":"crossref","first-page":"846","DOI":"10.5551\/jat.GL2017","article-title":"Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017","volume":"25","author":"Kinoshita","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2026.08.024_bib46","doi-asserted-by":"crossref","first-page":"8058","DOI":"10.3390\/jcm14228058","article-title":"Diagnostic and therapeutic challenges of homozygous and severe heterozygous familial hypercholesterolemia from clinical aspect-a single-center study","volume":"14","author":"N\u00e1dr\u00f3","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacl.2026.08.024_bib47","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.3390\/ijms24043224","article-title":"Genetic heterogeneity of familial hypercholesterolemia: repercussions for molecular diagnosis","volume":"24","author":"Di Taranto","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacl.2026.08.024_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.trsl.2022.12.002","article-title":"A new 165-SNP low-density lipoprotein cholesterol polygenic risk score based on next generation sequencing outperforms previously published scores in routine diagnostics of familial hypercholesterolemia","volume":"255","author":"Vanhoye","year":"2023","journal-title":"Transl Res"},{"key":"10.1016\/j.jacl.2026.08.024_bib49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jacl.2026.02.015","article-title":"Lipoprotein lipase DNA methylation in the adipose tissue of patients with persistent chylomicronemia","volume":"20","author":"Larouche","year":"2026","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2026.08.024_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103079","article-title":"Differential DNA methylation in familial hypercholesterolemia","volume":"61","author":"Reeskamp","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jacl.2026.08.024_bib51","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5551\/jat.GL2022","article-title":"Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2022","volume":"31","author":"Okamura","year":"2024","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jacl.2026.08.024_bib52","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.TR120001001","article-title":"FH through the retrospectoscope","volume":"62","author":"Thompson","year":"2021","journal-title":"J Lipid Res"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742600499X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742600499X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:10:57Z","timestamp":1791753057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742600499X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"alternative-id":["S193328742600499X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.08.024","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current challenges in diagnosing homozygous familial hypercholesterolemia: Insights from the historical evolution of diagnostic criteria","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}